Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section wording updated to say publications are automatically filled from PubMed and may not be about the study, and the revision version changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding lapse notice has been removed from the page, and the rest of the study details page remains unchanged.SummaryDifference0.3%

- Check42 days agoChange DetectedThe screenshots show formatting changes and last-updated date updates, with no changes to the study's primary objectives, inclusion/exclusion criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedAdds several date entries (including future dates) and removes some past dates, indicating an update to time-related information without clear changes to core content or pricing.SummaryDifference0.3%

- Check71 days agoChange DetectedAdds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference2%

- Check78 days agoChange Detected- Added: Revision: v3.1.0. - Removed: Electromagnetic Radiation, Magnetic Phenomena, Electromagnetic Phenomena, Revision: v3.0.2. The page now centers on a newer version and omits several previously listed topics.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.